Heligenics Inc

11:45 AM - 12:00 PM (PDT), Wednesday, June 15, 2022
Our products have many applications in increasing efficacy, drug development, Biosimilar and Biobetter discovery, drug lead prioritization, clinical trial design, faster recruitment, new indications, companion diagnostics, and discovery of new biologics. Heligenics is the sole producer of custom, experimental, whole-gene mutation-function libraries that impact molecular function, pathology, and the pharmaceutical industry.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Nevada
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Her2 companion diagnostic / INFbeta Biobetter
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
CEO
Heligenics